MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Chinese Expert Consensus and Recommendations on Sensing-guided Deep Brain Stimulation for Parkinson’s Disease: A Modified Delphi Study

    F. Liu, J. Wang, S. Mei, P. Li, W. Song, L. Qiao, J. Wang (Shanghai, China)

    Objective: To propose some well-accepted recommendations on sensing-guided deep brain stimulation for Parkinson's Disease. Background: Deep brain stimulation (DBS) has been widely accepted as a well-established neurosurgical…
  • 2026 International Congress

    Long‑term dose-effect patterns with incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in cervical dystonia: multicenter real‑world analysis

    B. Waeschle, P. Albrecht, J. Lee, T. Kölsche, R. Jansen, P. Sobolewski, S. Sánchez Valiente, E. López Valdés, P. Mir, S. Jesús, E. Ojeda Lepe, E. Papuć, P. Sánchez Alonso, G. Salazar, G. Comes, H. Stark (Frankfurt, Germany)

    Objective: To characterize long‑term dose-effect patterns for incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in cervical dystonia (CD) using a unified dose-effect parameter (DEff) and to compare complex‑free…
  • 2026 International Congress

    Advancing Mobility-Related Activities of Daily Living Monitoring in Parkinson’s Disease: A Systematic Review of Wearable Sensor Technologies

    S. Yamutai, R. Bhidayasiri, O. Phokeawvarangkul (Bangkok, Thailand)

    Objective: To systematically review current evidence on wearable sensor devices for the objective monitoring of mobility-related ADLs in patients with PD. Background: Detecting Activities of…
  • 2026 International Congress

    Long-term 5-year follow-up of unilateral FUS thalamotomy for essential tremor

    E. Natera-Villalba, E. Salinas, A. Huerta, A. Jiménez-Huete, GM. Díaz-Taveras, MA. Gorospe, A. Martín-Bastida, PM. Cortadi La-Villa, I. Avilés-Olmos, CA. Sánchez Catasús, A. Arcadi, LH. González-Quarante, J. Guridi, MC. Rodríguez Oroz (Pamplona, Spain)

    Objective: To assess the long-term efficacy and safety of Vim-FUS in ET patients treated at our centre. Background: Vim-FUS has emerged as an effective therapeutic…
  • 2026 International Congress

    Acceptability and feasibility of digital mobility assessment for Parkinson’s Disease: Perspectives from people with Parkinson’s, carers and health and social care professionals in Ghana and Kenya

    R. Mc Ardle, J. Lumsdon, B. Mghendi, E. Ame-Bruce, W. Animdife, M. Agoriwo, M. Cham, A. Akpalu, S. Del Din, L. Rochester, K. Brittain, R. Walker, N. Fothergill-Misbah (Newcastle upon Tyne, United Kingdom)

    Objective: To explore perspectives of people with Parkinson’s disease (PD), carers and health and social care professionals (HSCPs) in Ghana and Kenya on the acceptability…
  • 2026 International Congress

    Tremor in Oromandibular Dystonia

    A. Jain, S. Pandey (Faridabad, India)

    Objective: To determine the prevalence of tremor in patients with oromandibular dystonia, characterise its anatomical distribution relative to dystonic regions, and assess the relationship between…
  • 2026 International Congress

    Towards Biomarker-Driven Staging of Multiple System Atrophy Using Longitudinal Neurofilament Light Profiling

    L. Lei, R. Lee, P. Korlipara, V. Chelban, H. Houlden (London, United Kingdom)

    Objective: To evaluate neurofilament light chain (NfL) as a longitudinal biomarker of disease burden and progression in Multiple System Atrophy and to explore its potential role…
  • 2026 International Congress

    Representation of Women in Deep Brain Stimulation Trials in Movement Disorders: Protocol for a Systematic Review and Meta-analysis

    D. Garg, M. Auffret, M. Bruno, K. Smilowska, C. Kilbane, W. Kamel, M. Picillo, L. Ali (Delhi, India)

    Objective: To systematically evaluate the representation of women participants in clinical trials of deep brain stimulation (DBS) for movement disorders and to estimate pooled proportions…
  • 2026 International Congress

    Early Reduction in Cerebral Histamine 3 Receptor Expression in People with Huntington’s Disease: Results from the iMarkHD Study

    D. van Wamelen, M. Moretto, J. Badenoch, A. Calvano, P. Eze, M. Hartmann, Z. Kovkasyuk, C. Madrigal-Esquivel, O. Makos, N. Martin, A. Rangel-Cristales, J. Staunton, P. Tall, N. Palasits, A. Wood, F. Turkheimer, M. Veronese, S. Williams (London, United Kingdom)

    Objective: To quantify histamine 3 receptor (H3R) expression using positron emission tomography (PET) in people with Huntington’s disease (PwHD) across different stages of disease progression.…
  • 2026 International Congress

    Are we overlooking wearing off? Evaluating the role of the WOQ-9 questionnaire in routine Parkinson’s care

    G. Heery, B. Mohamed, J. Adenwalla (Cardiff, United Kingdom)

    Objective: 1. Evaluate clinicians’ ability to recognise wearing-off compared with the Wearing Off Questionnaire-9 (WOQ-9)2. Assess patient awareness of wearing-off symptoms Background: Wearing off is…
  • « Previous Page
  • 1
  • …
  • 161
  • 162
  • 163
  • 164
  • 165
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley